SLC7A11 and urinary bladder carcinoma: Recent studies have shown that the solute transporter family member SLC7A11 is not only a key component of the cystine/glutamate antiporter (XC system) but also an important regulator of bladder cancer resistance to cisplatin (Lo et al., 2008; Lewerenz et al., 2013).